Public Notifications

Pursuant to section 36 of the Health Professions Act, the Inquiry Committee has reached an agreement with registrant Janet Carol Parkins to change her registration status to Former Pharmacist and is no longer a registrant of the College.  

On March 12, 2015, the registrant dispensed allopurinol to a patient which interacted with her existing medication, azathioprine. The drug-drug interaction between allopurinol and azathioprine is serious and well-known.  The two medications were refilled (by other pharmacists) for the next two months until the patient began experiencing symptoms of pancytopenia and was admitted to the hospital.  The patient remained in the hospital for 18 days during which she received multiple blood transfusions and required blood tests to determine the cause of her symptoms.

The Inquiry Committee found that the registrant did not conduct a PharmaNet review and failed to detect the drug-drug interaction on one occasion. The registrant provided basic counselling to the patient at the time of releasing the drug but did not alert the patient of the drug-drug interaction.  The Inquiry Committee determined that in the interest of public safety, a 1-month suspension of the registrant’s licence and educational remediation was appropriate for addressing this incident.  In lieu of suspension and remediation, the registrant requested and reached an agreement with the Inquiry Committee to relinquish her licence. If the registrant applies for reinstatement of her licence in the future, she will be required to complete the remediation steps set out by the Inquiry Committee and will be subject to a practice audit.  

(Aug 12, 2016 – Limits and conditions removed)

The Inquiry Committee had previously suspended pharmacist registrant’s registration for an indefinite period on February 12, 2016. Pursuant to Section 36 of the Health Professions Act, the Inquiry Committee reinstated pharmacist registrant’s registration and had reached an agreement on March 16, 2016 in which the Registrant was asked to consent to certain limits and conditions. Those previous limits and conditions have been revised as follows:

• Return to work on a full-time basis (8 hours/day), on the condition that a medical assessment is completed after 2 weeks with the treating healthcare professional;

• Remain on medications as prescribed by healthcare professionals and medical providers; and

• Take only one (1) online course or study in May 2016 so that it is not too stressful.

This agreement remains in effect until April 22, 2021. The Inquiry Committee considers the agreement necessary to protect the public. The pharmacist registrant's name has been withheld pursuant to 39.3(4) of the Health Professions Act. 

Abdelhamid Bayoud has satisfied the terms of an agreement reached with the Inquiry Committee dated March 5, 2014.  Limits and conditions on Mr. Bayoud’s registration as a pharmacist have now been removed.

The Inquiry Committee, pursuant to section 36 of the Health Professions Act, has reached an agreement with the pharmacist registrant to voluntarily suspend the registration as a pharmacist effective February 27, 2016. The agreement remains in effect until further notice. The Inquiry Committee considers the agreement necessary to protect the public. The pharmacist registrant's name has been withheld pursuant to section 39.3(4) of the Health Professions Act.